Liraglutide attenuates hepatic iron levels and ferroptosis in db/db mice

Liver pathological changes are as high as 21%-78% in diabetic patients, and treatment options are lacking. Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor that is widely used in the clinic and is approved to treat obesity and diabetes. However, the specific protection mechanism needs to be...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Ji-Xian, An, Ji-Ren, Chen, Qi, Yang, Xin-Yue, Jia, Cui-Ling, Xu, Shan, Zhao, Ya-shuo, Ji, En-Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161873/
https://www.ncbi.nlm.nih.gov/pubmed/35311455
http://dx.doi.org/10.1080/21655979.2022.2051858

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161873/
https://www.ncbi.nlm.nih.gov/pubmed/35311455
http://dx.doi.org/10.1080/21655979.2022.2051858

Ejemplares similares